Bisoprolol fumarate
10 mg
Once daily
2 tablets (20 mg)
Swallow whole with some liquid, preferably in the morning on an empty stomach or with breakfast.
High blood pressure (hypertension) and Coronary heart disease (angina pectoris)
Untreated myocardial insufficiency (decompensated heart failure), recent myocardial infarction, shock, disturbances of atrioventricular conduction (AV block grades II and III), sick sinus syndrome, disturbed stimulus conduction between the sinoatrial node and atrium (sinoatrial block), extremely slow pulse (bradycardia with less than 50 beats/min) prior to the start of treatment, extremely low blood pressure (hypotension), bronchial asthma and advanced stages of peripheral circulatory disturbances, untreated phaeochromocytoma, pregnancy or lactation, and children.
Other antihypertensive drugs, reserpine, methyldopa, clonidine, guanfacine, nifedipine, calcium antagonists of the verapamil or diltiazem type, other antiarrhythmic agents, rifampicin, insulin, oral antihyperglycaemic agents.
Potentiation of the antihypertensive effect, leading to excessive blood pressure lowering.
Careful monitoring is required as the combination can potentiate the antihypertensive effect.
Intravenous administration of these agents is not recommended due to the risk of hypotension, bradycardia, and other arrhythmias.
It can slightly reduce the half-life of Bisoprolol, but an increase in dosage is generally not necessary.
The effect of these agents may be potentiated, and blood-glucose levels should be monitored regularly.
Tiredness, dizziness, mild headaches, perspiration, sleep disturbances, vivid dreams, depressive moods. These usually subside within 1-2 weeks.
Gastrointestinal disturbances (diarrhea, constipation, nausea, abdominal pain), skin reactions (erythema, pruritus), marked decrease in blood pressure, slow pulse rate, disturbance of AV conduction, tingling and a sensation of coldness in the limbs, muscle weakness, muscle cramp, reduced lacrimation, aggravation of intermittent claudication and Raynaud's phenomenon, intensification of myocardial insufficiency, difficulties in breathing in patients prone to bronchospastic reactions, impairment of glucose tolerance in elderly diabetic patients.
Careful monitoring of blood pressure and pulse rate, particularly at the start of treatment and with dosage changes. Inform the anaesthetist if the patient is taking B-Cor 10 before surgery or anesthesia. Exercise caution in diabetic patients, as B-Cor 10 can mask the symptoms of hypoglycaemia.
Discontinue B-Cor 10 and administer appropriate antidotes if necessary: atropine intravenously, orciprenaline slowly intravenously, and glucagon.
Long-term therapy
Gradually, under the supervision of a doctor, especially in patients with coronary artery disease. Abrupt discontinuation can be dangerous.
Store below 30°C.
3 x 10 film-coated tablets.
Afrab-Chem Ltd., Nigeria.